White Paper
A Quality by Design Approach Toward Manufacturing of Elastomeric Components
How Datwyler's most advanced manufacturing standard delivers zero-defect elastomeric components for the world's most sensitive injectable drug applications.
Status
Published
Format
White Paper
Language
English
Access
Registration Required
Resource Overview
About this White Paper
Datwyler's FirstLine® manufacturing concept represents the highest tier of the company's three-tiered production standard — Essential, Advanced, and FirstLine® — purpose-built for elastomeric components used in parenteral packaging of biologics, biosimilars, and sensitive small molecules. Grounded in a Quality by Design (QbD) philosophy and a zero-defect goal, FirstLine facilities in Belgium, India, and the USA operate under cGMP-compliant clean room conditions with full automation, 100% vision inspection, paperless production floors, and statistical process control. The platform addresses three critical pharmaceutical industry trends: the increasing complexity of injectable drug formulations and extractables/leachables (E/L) concerns, more stringent FDA and global regulatory expectations, and the need for a globally harmonized supply chain for container closure systems. Datwyler's proprietary fluoropolymer spray coating and best-in-class FM457 elastomer compound are exclusively manufactured within FirstLine, making it the preferred solution for drug manufacturers seeking the lowest particulate levels, superior chemical compatibility, and regulatory defensibility for their primary packaging components.
Access This Resource
Download the White Paper
Continue to access the full resource.
Access the White Paper
Quick access in under 30 seconds.
